Survival of Canadian Cancer Patients Influenced by Socioeconomic Status

by Kathy Jones on  August 02, 2010 at 7:55 PM Cancer News
  •   Print
  •   Share
  •   Comments
  •  Text 
Cancer patients from poorer communities have a greater chance of dying prematurely than individuals from more affluent backgrounds even though cancer stage at time of diagnosis is similar across socioeconomic groups, a new analysis has found.

Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that efforts are needed to understand and reduce disparities in the survival of cancer patients from different socioeconomic groups.

Christopher Booth, MD, FRCPC, of the Queen's University Cancer Research Institute in Ontario, Canada led a team that analyzed all cases of breast, colon, rectal, non-small cell lung, cervical, and laryngeal cancer diagnosed in Ontario, Canada from 2003 to 2007, as identified through the Ontario Cancer Registry. Patients were divided into groups based on median household income reported in the 2001 Canadian census.

The investigators observed only very modest differences in cancer stage at the time of diagnosis across socioeconomic groups, contrasting with much of the existing literature. "It is plausible that the lack of a strong association between stage of disease and socioeconomic status in our study relates to the presence of universal health coverage in Ontario which may facilitate access to primary care physicians and/or cancer screening," said Dr. Booth.

However, the researchers found that despite universal healthcare, significant differences in survival across socioeconomic groups persist in Ontario: overall and cancer-specific survival of patients from poorer communities was lower than that of patients residing in more affluent neighborhoods. "Contrary to what has been reported in studies from the U.S., we have found that stage of cancer at time of diagnosis does not account for any substantial component of the difference in survival across social groups," said Dr. Booth. Instead, factors such as differences in cancer biology, the presence of other illnesses, access to treatment, and quality of care might play a role. The authors noted that additional work is needed to better understand these factors and to develop strategies to reduce disparities in the survival of patients with cancer.



Source-Eurekalert

 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X
  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
Quiz on Cancer
Looking for information on cancer? Go through medindia's Cancer quiz.
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Cancer
Complete Medindia Resources
News Categories:  
Men's Health Center

Cancer Related News

» Cardio-Pulmonary Function can be a Strong Indicator for Survival Chances of Breast Cancer Patients » Post Surgery Will the Tumour Return? New Breast Cancer Test to Predict Exactly
» Scientists Develop Compound That Triggers Cancer Cell Death » Iraqi National Hopes to Find Affordable Treatment for His Cancer in India
» New Technique can Help Doctors Detect Pancreatic Cancer » Colorectal Cancer Risk Factors Probed
» Breast MRI 'Better Than Clinical Approach for Predicting Chemotherapy's Efficiency' » No Need for PSA-Based Screening for Prostate Cancer: Task Force
Read More >>